BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 28254074)

  • 21. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].
    Ikemoto H; Ito C; Yoshida T; Watanabe K; Mori T; Ohno I; Okada S; Igari J; Arakawa M; Igarashi K; Oguri T; Okada M; Ozaki K; Terai T; Aoki N; Inoue H; Nakadate T; Kitamura N; Sekine O; Suzuki Y; Ando M; Suga M; Sato K; Nakata K; Kusano N
    Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010).
    Farrell DJ; Castanheira M; Mendes RE; Sader HS; Jones RN
    Clin Infect Dis; 2012 Sep; 55 Suppl 3():S206-14. PubMed ID: 22903953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of polyamidoamine (PAMAM) dendrimers as drug carriers of anti-bacterial drugs using sulfamethoxazole (SMZ) as a model drug.
    Ma M; Cheng Y; Xu Z; Xu P; Qu H; Fang Y; Xu T; Wen L
    Eur J Med Chem; 2007 Jan; 42(1):93-8. PubMed ID: 17095123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1992)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Tanimoto H; Nakata K; Nakamori Y; Nakatani T; Kusano N
    Jpn J Antibiot; 1996 Jan; 49(1):34-70. PubMed ID: 8851305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibacterial agents (2008)].
    Goto H; Iwasaki M
    Jpn J Antibiot; 2015 Feb; 68(1):19-36. PubMed ID: 25980051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of natural antimicrobials to increase antibiotic susceptibility of drug resistant bacteria.
    Palaniappan K; Holley RA
    Int J Food Microbiol; 2010 Jun; 140(2-3):164-8. PubMed ID: 20457472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibacterial agents (2010)].
    Goto H; Iwasaki M
    Jpn J Antibiot; 2015 Apr; 68(2):85-104. PubMed ID: 26182813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An efficient method for synthesis, characterization and molecular docking study of new sulfamethoxazole derivatives as antibacterial agents.
    Khan AK; Hamdi MD; Razik BMA
    Pak J Pharm Sci; 2021 May; 34(3):825-833. PubMed ID: 34602403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The crystal structure of sulfamethoxazole, interaction with DNA, DFT calculation, and molecular docking studies.
    Das D; Sahu N; Roy S; Dutta P; Mondal S; Torres EL; Sinha C
    Spectrochim Acta A Mol Biomol Spectrosc; 2015 Feb; 137():560-8. PubMed ID: 25240147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acquired resistance to trimethoprim-sulfamethoxazole during Whipple disease and expression of the causative target gene.
    Bakkali N; Fenollar F; Biswas S; Rolain JM; Raoult D
    J Infect Dis; 2008 Jul; 198(1):101-8. PubMed ID: 18500934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation and identification of antibacterial compounds from Thymus kotschyanus aerial parts and Dianthus caryophyllus flower buds.
    Mohammed MJ; Al-Bayati FA
    Phytomedicine; 2009 Jun; 16(6-7):632-7. PubMed ID: 19200700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis and biological evaluation of novel aryldiketo acids with enhanced antibacterial activity against multidrug resistant bacterial strains.
    Cvijetić IN; Verbić TŽ; Ernesto de Resende P; Stapleton P; Gibbons S; Juranić IO; Drakulić BJ; Zloh M
    Eur J Med Chem; 2018 Jan; 143():1474-1488. PubMed ID: 29133041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibacterial agents (2007)].
    Goto H; Iwasaki M
    Jpn J Antibiot; 2015 Feb; 68(1):1-18. PubMed ID: 25980050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibacterial agents (2009)].
    Goto H; Kumagai S
    Jpn J Antibiot; 2015 Feb; 68(1):37-54. PubMed ID: 25980052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibacterial agents (2011)].
    Goto H; Iwasaki M
    Jpn J Antibiot; 2015 Apr; 68(2):105-24. PubMed ID: 26182814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New acrylamide-sulfisoxazole conjugates as dihydropteroate synthase inhibitors.
    Nasr T; Bondock S; Ibrahim TM; Fayad W; Ibrahim AB; AbdelAziz NA; Sakr TM
    Bioorg Med Chem; 2020 May; 28(9):115444. PubMed ID: 32220521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemical composition and antibacterial activity of the essential oils from flower, leaf and stem of Ferula cupularis growing wild in Iran.
    Alipour Z; Taheri P; Samadi N
    Pharm Biol; 2015 Apr; 53(4):483-7. PubMed ID: 25471700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular properties prediction, synthesis and antimicrobial activity of some newer oxadiazole derivatives.
    Bakht MA; Yar MS; Abdel-Hamid SG; Al Qasoumi SI; Samad A
    Eur J Med Chem; 2010 Dec; 45(12):5862-9. PubMed ID: 20965619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, molecular docking and biological evaluation of metronidazole derivatives containing piperazine skeleton as potential antibacterial agents.
    Wang SF; Yin Y; Qiao F; Wu X; Sha S; Zhang L; Zhu HL
    Bioorg Med Chem; 2014 Apr; 22(8):2409-15. PubMed ID: 24680059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2003)].
    Goto H; Takeda H; Kawai S; Nakadate T; Shimada K; Nakano K; Suwabe A; Yokouchi H; Okada S; Ashino Y; Ikemoto H; Gejyo F; Igari J; Okada M; Oguri T; Aoki N; Mori T; Yamamoto M; Kitamura N; Inoue H; Suzuki Y; Karasawa Y; Tosaka M; Kudo K; Kobayashi N; Kohno S; Tanaka T; Hirakata Y; Kondo A; Matsuda J; Nakano M; Sumitomo M; Nasu M; Niki Y; Hiramatsu K; Suga M; Suzuki Y
    Jpn J Antibiot; 2005 Jun; 58(3):326-58. PubMed ID: 16161758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.